Abstract
Migraine is a common neurological disorder that impacts approximately 12% of the general population and is characterized by moderate to severe headaches, nausea, mood changes, and fatigue. It impacts lower-level visual and auditory processing, causing hypersensitivities that lead to heightened audiovisual multisensory integration. However, the impact of migraine on the processing of complex, audiovisual stimuli is still unclear. Additionally, migraine may induce hypersensitivities to emotional arousal and valence, though the relative significance of these factors remains unknown. The current study seeks to identify how migraine impacts synchronous neural processing of complex, audiovisual stimuli, and how this differs based on the emotional arousal and valence of the stimulus. To do so, we collected functional magnetic resonance imaging data from 22 migraineurs and 21 healthy controls during the passive viewing of three audiovisual films of differing emotional arousal and valence. We identified that, in response to a negative valence, high arousal emotional stimulus, the migraine group showed greater neural synchrony in regions associated with multisensory integration, including the bilateral posterior superior temporal gyrus (pSTG), superior parietal lobule (SPL), and left middle temporal gyrus (MTG). There were no significant differences in neural synchrony between the migraine and control groups in response to positive valence, high arousal and neutral valence, low arousal stimuli. These findings suggest that migraine involves hypersensitivity to audiovisual movies as a function of negative emotional valence, where negative/aversive emotional states may drive greater synchrony in multisensory integration. Overall, this research highlights distinct pathways through which emotion and arousal impact neural processing in migraine.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by a NSERC Discovery Grant and NSERC Discovery Launch Supplement to C.E. and an NSERC PGS-D Scholarship to K.K.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of University of Alberta gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.